Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2631-2637

  Margolin, K ^a   Doroshow, J H ^a   Ahn, C ^a   Hamasaki, V ^a   Leong, L ^a   Morgan, R ^a   Raschko, J ^a   Shibata, S ^a   Somlo, G ^a   Tetef, M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

ABDOMINAL PAIN; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CHORIOCARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG SAFETY; EMBRYONAL CARCINOMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SEMINOMA; TREATMENT OUTCOME;

EID: 10144242638     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2631     Document Type: Article

References (21)

1. Einhorn LH: Testicular cancer as a model for curable neoplasm. The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 41:3275-3280, 1981
2. Motzer RJ, Bosl GJ: High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions. J Natl Cancer Inst 84:1703-1709, 1992
3. Birch R, Williams S, Cone A: Prognostic factors for response in disseminated germ cell tumors. J Clin Oncol 4:400-407, 1984
4. Mead GM: International consensus prognostic classification for metastatic germ cell tumours treated with platinum based chemotherapy; Final report of the International Germ Cell Cancer Collaborative Group. Proc Am Soc Clin Oncol 14:235, 1995 (abstr)
5. Elias AD, Ayash LJ, Eder JP, et al: A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support. J Clin Oncol 9:320-327, 1991
6. Wilson WH, Jain V, Bryant G, et al: Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors. J Clin Oncol 10:1712-1722, 1992
7. Fox EP, Loehrer PJ: Chemotherapy for advanced testicular cancer, in Greco FA, Hainsworth JD (eds): Hematology/Oncology Clinics of North America. Philadelphia, PA, Saunders, 1991, pp 1173-1187
8. Toner GC, Geller NL, Tan C: Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors. Cancer Res 50:5904-5910, 1990
9. Richardson RL, Schoumacher RA, Fer MF: The unrecognized extragonadal germ cell cancer syndrome. Ann Intern Med 94:181-186, 1981
10. Goss PE, Schwertfeger L, Blackstein ME: Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer 73:1971-1979, 1994
11. Somlo G, Doroshow JH, Forman SJ: High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem-cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer. Cancer 73:125-134, 1994
12. Somlo G, Doroshow JH, Forman SJ: High-dose doxorubicin, etoposide and cyclophosphamide with stem-cell reinfusion in patients with metastatic or high-risk primary breast cancer. Cancer 73:1678-1685, 1994
13. Nichols CR, Tricot G, Williams SD: Dose-intensive chemotherapy in refractory germ cell cancer - A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939, 1989
14. Nichols CR, Andersen J, Lazarus HM: High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group protocol. J Clin Oncol 10:558-563, 1992
15. Droz JP, Pico JL, Ghosn M: Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer. Eur J Cancer 27:831-835, 1991
16. Broun ER, Nichols CR, Turns M: Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Cancer 73:1716-1720, 1994
17. Linkesch W, Greinix HT, Höcker P: Long term follow up of phase I/II trial of ultra-high carboplatin, VP16, cyclophosphamide with ABMT in refractory or relapsed NSGCT. Proc Am Soc Clin Oncol 12:232, 1993
18. Rodenhuis S, van der Wall E, ten Bokkel Huinink WW: Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer. Cancer Invest 13:355-362, 1995
19. Bajorin DF, Herr H, Motzer RJ: Current perspectives on the role of adjunctive surgery in combined modality treatment for patients with germ cell tumors. Semin Oncol 19:148-158, 1992
20. Fox EP, Weathers TD, Williams SD: Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 11:1294-1299, 1993
21. Bosl GJ, Geller NL, Bajorin D: Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumors. Cancer 67:1299-1304, 1991